Decheng Capital Founded 2011
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$89M
Portfolio companies 11
Rounds per year 1.10
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits -
Key employees -
Stages of investment
Private Equity
Seed
Venture
Summary

Decheng Capital is the famous VC, which was founded in 2011. The venture was found in Asia in China. The main office of represented VC is situated in the Shanghai.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Decheng Capital, startups are often financed by Sofinnova Investments, Lilly Asia Ventures, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, OrbiMed, Celgene. In the next rounds fund is usually obtained by XSeed Capital, Wooshin Venture Investment Corp., South China Venture Capital.

Among the most popular portfolio startups of the fund, we may highlight luckin coffee, ARMO BioSciences, Mindstrong Health. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Biopharma. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

Comparing to the other companies, this Decheng Capital performs on 10 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2018. The real fund results show that this VC is 28 percentage points more often commits exit comparing to other companies. The typical startup value when the investment from Decheng Capital is more than 1 billion dollars. The top amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year.

The overall number of key employees were 3.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Terns Pharmaceuticals
Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Series B
80M30 Oct 2018
Apexigen
Biopharma
Biotechnology
Health Care
Pharmaceutical
Series C
65M24 Mar 2020 United States, Burlingame
Sema4
Artificial Intelligence
Health Care
Health Diagnostics
Medical
Predictive Analytics
Series B
120M30 Aug 2019 United States, Stamford
Omniome
Biopharma
Biotechnology
Life Science
Series B
60M31 Jul 2018 United States, San Diego
Omniome
Biopharma
Biotechnology
Life Science
Series C
60M09 Jan 2020 United States, San Diego
GeneWEAVE
Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Series B
12M20 Jun 2014 United States, Los Gatos
Apexigen
Biopharma
Biotechnology
Health Care
Pharmaceutical
Series B
15M08 May 2021 United States, Burlingame
VelosBio
Series B
137M08 May 2021
Sema4
Artificial Intelligence
Health Care
Health Diagnostics
Medical
Predictive Analytics
Series C
121M08 May 2021 United States, Stamford
Encodia
Biotechnology
Chemical
Series C
75M08 May 2021 United States, San Diego
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Decheng Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: